|
業務類別
|
Biotechnology |
|
業務概覽
|
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301. |
| 公司地址
| 1841 Page Mill Road, Suite 100, Palo Alto, CA, USA, 94304 |
| 電話號碼
| +1 925 247-4481 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.evommune.com |
| 員工數量
| 48 |
| Mr. Gregory S. Moss |
Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer |
-- |
17/10/2025 |
| Mr. Luis C. Pena |
Director, President and Chief Executive Officer |
-- |
17/10/2025 |
| Ms. Janice Drew, M.P.H. |
Executive Vice President, Operations |
-- |
17/10/2025 |
| Mr. Kyle Carver, C.P.A.,M.B.A. |
Chief Financial Officer |
-- |
17/10/2025 |
| Mr. Jeegar Patel |
Chief Scientific Officer |
-- |
17/10/2025 |
| Dr. Eugene A. Bauer,M.D. |
Director and Chief Medical Officer |
-- |
17/10/2025 |
|
|
| Mr. Francois Beaubien |
Director |
17/10/2025 |
| Mr. Felice Verduyn-van Weegen |
Independent Director |
17/10/2025 |
| Mr. Luis C. Pena |
Director, President and Chief Executive Officer |
17/10/2025 |
| Mr. David Eric Cohen |
Director |
17/10/2025 |
| Dr. Robert Hopfner, M.B.A. |
Independent Director |
17/10/2025 |
| Dr. Benjamin F. McGraw,III,Pharm.D. |
Chairman of the Board |
17/10/2025 |
| Mr. Arthur S. Kirsch |
Independent Director |
17/10/2025 |
| Dr. Derek DiRocco, PhD |
Independent Director |
17/10/2025 |
| Mr. Yuexin Xu |
Director |
17/10/2025 |
| Dr. Eugene A. Bauer,M.D. |
Director and Chief Medical Officer |
17/10/2025 |
|
|
|
|
